首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife
【2h】

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife

机译:通过标准化用电子刀治疗的前列腺癌患者的剂量限制提高计划质量和一致性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treatment plans for prostate cancer patients undergoing stereotactic body radiation therapy (SBRT) are often challenging due to the proximity of organs at risk. Today, there are no objective criteria to determine whether an optimal treatment plan has been achieved, and physicians rely on their personal experience to evaluate the plan's quality. In this study, we propose a method for determining rectal and bladder dose constraints achievable for a given patient's anatomy. We expect that this method will improve the overall plan quality and consistency, and facilitate comparison of clinical outcomes across different institutions. The 3D proximity of the organs at risk to the target is quantified by means of the expansion‐intersection volume (EIV), which is defined as the intersection volume between the target and the organ at risk expanded by 5 mm. We determine a relationship between EIV and relevant dosimetric parameters, such as the volume of bladder and rectum receiving 75% of the prescription dose (V75%). This relationship can be used to establish institution‐specific criteria to guide the treatment planning and evaluation process.A database of 25 prostate patients treated with CyberKnife SBRT is used to validate this approach. There is a linear correlation between EIV and V75% of bladder and rectum, confirming that the dose delivered to rectum and bladder increases with increasing extension and proximity of these organs to the target. This information can be used during the planning stage to facilitate the plan optimization process, and to standardize plan quality and consistency. We have developed a method for determining customized dose constraints for prostate patients treated with robotic SBRT. Although the results are technology‐specific and based on the experience of a single institution, we expect that the application of this method by other institutions will result in improved standardization of clinical practice.PACS numbers: 87.55.‐x, 87.55.D‐, 87.55.de, 87.55.dk
机译:接受立体定向放射治疗(SBRT)的前列腺癌患者的治疗计划通常具有挑战性,因为这些器官靠近危险器官。如今,尚无客观标准来确定是否已实现最佳治疗计划,并且医生依靠其个人经验来评估计划的质量。在这项研究中,我们提出了一种确定给定患者解剖结构可达到的直肠和膀胱剂量限制的方法。我们希望这种方法将改善总体计划的质量和一致性,并促进不同机构之间临床结果的比较。可通过扩张相交体积(EIV)量化处于危险中的器官与目标的3D接近度,该体积定义为目标与处于危险中的器官之间的相交体积扩大5 mm。我们确定EIV与相关剂量参数之间的关系,例如接受处方剂量的75%(V75%)的膀胱和直肠体积。这种关系可用于建立特定于机构的标准,以指导治疗计划和评估过程。使用Cyber​​Knife SBRT治疗的25名前列腺患者的数据库用于验证该方法。 EIV与膀胱和直肠的V75%之间存在线性关系,这证实了随着这些器官向靶标的延伸和接近程度的增加,递送至直肠和膀胱的剂量也会增加。可以在计划阶段使用此信息以促进计划优化过程,并使计划质量和一致性标准化。我们已经开发出一种方法,可以确定用机器人SBRT治疗的前列腺患者的定制剂量限制。尽管结果是特定于技术的,并且基于单个机构的经验,但我们希望其他机构应用此方法将改善临床实践的标准化.PACS编号:87.55.-x,87.55.D-, 87.55.de,87.55.dk

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号